Suppr超能文献

大肠杆菌功能性五聚体热不稳定肠毒素B亚基在酿酒酵母中的表达。

Expression of functional pentameric heat-labile enterotoxin B subunit of Escherichia coli in Saccharomyces cerevisiae.

作者信息

Lim Jung-Gu, Kim Jung-Ae, Chung Hea-Jong, Kim Tae-Geum, Kim Jung-Mi, Lee Kyung-Ryul, Park Seung-Moon, Yang Moon-Sik, Kim Dae-Hyuk

机构信息

Institute for Molecular Biology and Genetics, Research Center of Bioactive Materials, Chonbuk National University, Jeonju 561-756, Korea.

出版信息

J Microbiol Biotechnol. 2009 May;19(5):502-10. doi: 10.4014/jmb.0803.207.

Abstract

Although the Escherichia coli heat-labile enterotoxin B subunit (LTB) has already been expressed in several different systems, including prokaryotic and eukaryotic organisms, studies regarding the synthesis of LTB into oligomeric structures of pentameric size in the budding yeast Saccharomyces cerevisiae have been limited. Therefore, this study used a functional signal peptide of the amylase 1A protein from rice to direct the yeast-expressed LTB towards the endoplasmic reticulum to oligomerize with the expected pentameric size. The expression and assembly of the recombinant LTB were confirmed in both the cell-free extract and culture media of the recombinant strain using a Western blot analysis. The binding of the LTB pentamers to intestinal epithelial cell membrane glycolipid receptors was further verified using a GM1-ganglioside enzyme-linked immunosorbent assay (GM1-ELISA). On the basis of the GM1-ELISA results, pentameric LTB proteins comprised approximately 0.5-2.0% of the total soluble proteins, and the maximum quantity of secreted LTB was estimated to be 3 mg/l after a 3-day cultivation period. Consequently, the synthesis of LTB monomers and their assembly into biologically active oligomers in a recombinant S. cerevisiae strain demonstrated the feasibility of using a GRAS microorganism-based adjuvant, as well as the development of carriers against mucosal disease.

摘要

尽管大肠杆菌热不稳定肠毒素B亚基(LTB)已在包括原核生物和真核生物在内的多种不同系统中表达,但关于在出芽酵母酿酒酵母中将LTB合成五聚体大小的寡聚结构的研究仍然有限。因此,本研究使用来自水稻的淀粉酶1A蛋白的功能性信号肽,将酵母表达的LTB导向内质网,使其以预期的五聚体大小寡聚化。使用蛋白质印迹分析在重组菌株的无细胞提取物和培养基中证实了重组LTB的表达和组装。使用GM1-神经节苷脂酶联免疫吸附测定(GM1-ELISA)进一步验证了LTB五聚体与肠上皮细胞膜糖脂受体的结合。根据GM1-ELISA结果,五聚体LTB蛋白约占总可溶性蛋白的0.5-2.0%,培养3天后分泌的LTB最大量估计为3 mg/l。因此,在重组酿酒酵母菌株中LTB单体的合成及其组装成生物活性寡聚体证明了使用基于公认安全(GRAS)微生物的佐剂以及开发抗粘膜疾病载体的可行性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验